Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mar Guilarte

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
The American Journal of Gastroenterology|August 3, 2020
Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel SyndromeMar Guilarte, María Vicario, Cristina Martínez, et al.
Gut|September 12, 2014
Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestationsMaria Vicario, Ana M González-Castro, Cristina Martínez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Familial mast cell-mediated angioedema: Description of 4 familiesMarina Sabaté-Brescó, Mar Guilarte, Gorka Alkorta-Aranburu, et al.
Health and Quality of Life Outcomes|July 24, 2012
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research projectNieves Prior, Eduardo Remor, Carmen Gómez-Traseira, et al.
United European Gastroenterology Journal|October 14, 2017
Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot studyBeatriz Lobo, Laura Ramos, Cristina Martínez, et al.
Advances in Therapy|June 10, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema ProphylaxisTimothy J Craig, Mar Guilarte, Huamin Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2021
Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other SeriesMaria L Baeza, Teresa González-Quevedo, Teresa Caballero, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 22, 2013
[Algorithm for diagnosis and treatment of hereditary angioedema as a tool for management]María Luisa Baeza, Teresa Caballero Molina, Carlos Crespo Diz, et al.
Journal of Asthma and Allergy|March 2, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1William R Lumry, Raffi Tachdjian, Timothy Craig, et al.
Orphanet Journal of Rare Diseases|May 21, 2024
Hereditary angioedema in Spain: medical care and patient journeyTeresa Caballero, Carmen Alonso, María Luisa Baeza, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The American Journal of Gastroenterology|August 3, 2020
Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel SyndromeMar Guilarte, María Vicario, Cristina Martínez, et al.
Gut|September 12, 2014
Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestationsMaria Vicario, Ana M González-Castro, Cristina Martínez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Familial mast cell-mediated angioedema: Description of 4 familiesMarina Sabaté-Brescó, Mar Guilarte, Gorka Alkorta-Aranburu, et al.
Health and Quality of Life Outcomes|July 24, 2012
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research projectNieves Prior, Eduardo Remor, Carmen Gómez-Traseira, et al.
United European Gastroenterology Journal|October 14, 2017
Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot studyBeatriz Lobo, Laura Ramos, Cristina Martínez, et al.
Advances in Therapy|June 10, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema ProphylaxisTimothy J Craig, Mar Guilarte, Huamin Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2021
Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other SeriesMaria L Baeza, Teresa González-Quevedo, Teresa Caballero, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 22, 2013
[Algorithm for diagnosis and treatment of hereditary angioedema as a tool for management]María Luisa Baeza, Teresa Caballero Molina, Carlos Crespo Diz, et al.
Journal of Asthma and Allergy|March 2, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1William R Lumry, Raffi Tachdjian, Timothy Craig, et al.
Orphanet Journal of Rare Diseases|May 21, 2024
Hereditary angioedema in Spain: medical care and patient journeyTeresa Caballero, Carmen Alonso, María Luisa Baeza, et al.
Pageof 8